Inhibition of the Epstein-Barr virus lytic cycle by moronic acid.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Antiviral Research

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.antiviral.2009.12.002PMID 19969023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replication

  2009influential reference
• Epstein-Barr Virus Immediate-Early Protein Zta Co-Opts Mitochondrial Single-Stranded DNA Binding Protein To Promote Viral and Inhibit Mitochondrial DNA Replication

  2008cited by this paper
• Inhibition of the epstein-barr virus lytic cycle by andrographolide.

  2008cited by this paper
• A new benzofuranone and anti-HIV constituents from the stems of Rhus chinensis.

  2007cited by this paper
• A comprehensive library of mutations of Epstein Barr virus.

  2007cited by this paper
• Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.

  2006influential reference
• Activation of Sp1-mediated transcription by Rta of Epstein–Barr virus via an interaction with MCAF1

  2005cited by this paper
• Epstein-Barr virus infections: prospects for treatment.

  2005cited by this paper
• Post-translational Modification of Rta of Epstein-Barr Virus by SUMO-1*

  2004influential reference
• Effects of Maribavir and Selected Indolocarbazoles on Epstein-Barr Virus Protein Kinase BGLF4 and on Viral Lytic Replication

  2004cited by this paper
• Cytotoxic triterpenoids from Acridocarpus vivy from the Madagascar rain forest.

  2004cited by this paper
• The End of Innocence

  2004cited by this paper
• Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate.

  2003cited by this paper
• Persistent epstein-barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients1

  2002cited by this paper
• Phosphorylation of the Epstein-Barr Virus (EBV) DNA Polymerase Processivity Factor EA-D by the EBV-Encoded Protein Kinase and Effects of the l-Riboside Benzimidazole 1263W94

  2002cited by this paper
• Cytotoxic activity of moronic acid and identification of the new triterpene 3,4-seco-olean-18-ene-3,28-dioic acid from Phoradendron reichenbachianum.

  2001cited by this paper
• Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites

  2001cited by this paper
• Anti-AIDS agents. 48.(1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis.

  2001cited by this paper
• The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators

  2000cited by this paper
• Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo.

  1999cited by this paper
• Role of Rta in the Translation of Bicistronic BZLF1 of Epstein-Barr Virus

  1998cited by this paper
• Epstein-Barr viral gene expression in B-lymphocytes.

  1998cited by this paper
• Identification of functional targets of the Zta transcriptional activator by formation of stable preinitiation complex intermediates

  1994cited by this paper
• "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs

  1994cited by this paper
• The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region.

  1993cited by this paper
• Pathways of activation of the Epstein-Barr virus productive cycle

  1991cited by this paper
• Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis.

  1991cited by this paper
• The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner

  1990cited by this paper
• The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent

  1989cited by this paper
• Epstein‐Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans‐activators.

  1989cited by this paper
• The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators

  1989cited by this paper
• T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

  1988cited by this paper
• Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells

  1987cited by this paper
• Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis.

  1986cited by this paper
• Acyclovir inhibition of Epstein-Barr virus replication.

  1980cited by this paper
• Moronic Acid, a Simple Triterpenoid Keto Acid with Antimicrobial Activity Isolated from Ozoroa mucronata1

  1979cited by this paper
• Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

  1979cited by this paper
• EB viral genomes in epithelial nasopharyngeal carcinoma cells.

  1973cited by this paper
• Observations on childhood infections with the Epstein-Barr virus.

  1970cited by this paper

• Selected Pentacyclic Triterpenoids and Their Derivatives as Biologically Active Compounds

  2025cites this paper
• Investigating small molecules in propolis as Nipah virus glycoprotein (NiV-G) inhibitors through molecular interaction studies

  2025cites this paper
• Treatment of Epstein-Barr Virus infection in immunocompromised patients.

  2024cites this paper
• Update of Natural Products and Their Derivatives Targeting Epstein–Barr Infection

  2024cites this paper
• The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death

  2023cites this paper
• The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond

  2023cites this paper
• Chemical and cytotoxicity profiles of 11 pink pepper (Schinus spp.) samples via non-targeted hyphenated high-performance thin-layer chromatography

  2023cites this paper
• In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach

  2023cites this paper
• Nano-assembly of cytotoxic amides of moronic and morolic acid.

  2023cites this paper
• Anti-Epstein-Barr Viral Agents from the Medicinal Herb-Derived Fungus Alternaria alstroemeriae Km2286.

  2022cites this paper
• Phytochemical characteristics and biological activities of Rhus chinensis Mill.: a review

  2022cites this paper
• A comprehensive review on ethnobotanical, phytochemical and pharmacological aspects of Rhus chinensis Mill.

  2022cites this paper
• Andrographolide Inhibits Epstein–Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins

  2022cites this paper
• Chemical Components of Polygonum cuspidatum Ethylacetate Subfraction and their Effects on Epstein-Barr Virus Lytic Genes Expression

  2022cites this paper
• The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases

  2021influential citation
• Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study

  2021cites this paper
• Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections

  2021cites this paper
• Effect of dietary sodium butyrate on the innate immune response of Procambarus clarkii and disease resistance against white spot syndrome virus

  2021cites this paper
• MORONIC ACID: A REVIEW

  2021cites this paper
• Moronic acid: An antiviral for herpes simplex virus

  2021cites this paper
• Novel Therapeutics for Epstein–Barr Virus

  2019cites this paper
• Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis

  2019cites this paper
• Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle.

  2019cites this paper
• Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies

  2018cites this paper
• Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives

  2018cites this paper
• Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin

  2017cites this paper
• Chemical characterization and cytotoxic activity evaluation of Lebanese propolis.

  2017cites this paper
• Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.

  2016cites this paper
• EBV reactivation as a target of luteolin to repress NPC tumorigenesis

  2016cites this paper
• Chromatin Structure of Epstein-Barr Virus Latent Episomes.

  2015cites this paper
• Activation and Repression of Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycles by Short- and Medium-Chain Fatty Acids

  2014cites this paper
• undifferentiated nasopharyngeal carcinoma

  2013cites this paper
• Antimicrobial activity of Schinus lentiscifolius (Anacardiaceae).

  2013cites this paper
• Erratum to: Bioactive activities of natural products against herpesvirus infection

  2013cites this paper
• Characterization of Epstein–Barr virus reactivation in a modeled spaceflight system

  2013cites this paper
• Role of RNF 4 in the ubiquitination of Rta of Epstein-Barr virus

  2013cites this paper
• Role of RNF4 in the Ubiquitination of Rta of Epstein-Barr Virus*

  2013cites this paper
• EBV-associated cancers: Strategies for targeting the virus

  2013cites this paper
• Sulfated Small Molecules Targeting EBV in Burkitt Lymphoma: From In Silico Screening to the Evidence of In Vitro Effect on Viral Episomal DNA

  2013cites this paper
• Bioactive activities of natural products against herpesvirus infection

  2013cites this paper
• Reactive oxygen species, NF-kB, and p53 levels in tissue of undifferentiated nasopharyngeal carcinoma -

  2013cites this paper
• Inhibitory Effects of Brazilian Propolis on Tumor Promotion in Two-Stage Mouse Skin Carcinogenesis

  2012cites this paper
• Propolis: Alternative Medicine for the Treatment of Oral Microbial Diseases

  2012cites this paper
• Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.

  2011cites this paper
• Caractérisation de l'ubinucléine, partenaire cellulaire du transactivateur ZEBRA du virus d'Epstein-Barr

  2010cites this paper